Risk-Stratified Treatment in Chronic Lymphocytic Leukemia

por Stephens, Deborah M., Goodrich, Amy L.
Publicado 2016

ODP090 Fragility Fractures and Osteoporosis Screening in Patients with Chronic Lymphocytic Leukemia

por Petty, Lloyd, Stephens, Deborah, Sharma, Anu
Publicado 2022

Maslow on management

por Maslow, Abraham H, Stephens, Deborah C, Heil, Gary, Maslow, Abraham H
Publicado 1998

1087. Evaluation of Risk Factors for Infection among Patients Receiving Ibrutinib

por Tham, Kenneth, Prelewicz, Stacy, deHoll, Sara, Stephens, Deborah, Gomez, Carlos A
Publicado 2020

Folliculocentric lymphocytic hypersensitivity reactions in CLL/SLL patients: A unique clinicopathologic entity amongst non‐specific hypersensitivity reactions

por Abbott, James, Corean, Jessica, Snyder, Ashley M., Florell, Scott R., Miles, Rodney, Stephens, Deborah, Wada, David A.
Publicado 2023

P621: REAL-WORLD DOSING PATTERNS AND TIME TO NEXT TREATMENT FOR PREVIOUSLY UNTREATED PATIENTS WITH CLL/SLL WITH OR WITHOUT IBRUTINIB DOSE REDUCTION FOLLOWING AN ADVERSE EVENT

por Shadman, Mazyar, Srivastava, Bhavini, Patel, Sima, Saifan, Chadi, Salkar, Monika, Emond, Bruno, Gogna, Priyanka, Manceur, Ameur, Lafeuille, Marie-Helene, Stephens, Deborah
Publicado 2023

Secondary malignancies in non‐Hodgkin lymphoma survivors: 40 years of follow‐up assessed by treatment modality

por Parsons, Matthew W., Rock, Calvin, Chipman, Jonathan J., Shah, Harsh R., Hu, Boyu, Stephens, Deborah M., Tao, Randa, Tward, Jonathan D., Gaffney, David K.
Publicado 2022

P644: IBRUTINIB DOSE MODIFICATIONS FOR MANAGEMENT OF CARDIAC ADVERSE EVENTS IN PATIENTS WITH B-CELL MALIGNANCIES: POOLED ANALYSIS OF 10 CLINICAL TRIALS

por Stephens, Deborah, R. Brown, Jennifer, MA, Shuo, Wang, Michael, Moreno, Carol, Robak, Tadeusz, Stevens, Don, Lee, Shane, Saifan, Chadi, Hsu, Emily, Patel, Sima, Burger, Jan
Publicado 2023

Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells

por Luo, Chengke, Deng, Zhenghao, Li, Lan, Clayton, Frederic, Chen, Alexander L., Wei, Ran, Miles, Rodney, Stephens, Deborah M., Glenn, Martha, Wang, Xiyang, Jensen, Peter E., Chen, Xinjian
Publicado 2016

Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates CXCR4 in inherited risk

por Feusier, Julie E., Madsen, Michael J., Avery, Brian J., Williams, Justin A., Stephens, Deborah M., Hu, Boyu, Osman, Afaf E. G., Glenn, Martha J., Camp, Nicola J.
Publicado 2021

P628: UPDATED ANALYSIS OF BELLWAVE-001: A PHASE 1/2 OPEN-LABEL DOSE-EXPANSION STUDY OF THE EFFICACY AND SAFETY OF NEMTABRUTINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES

por Woyach, Jennifer, Flinn, Ian W., Awan, Farrukh, Eradat, Herbert, Brander, Danielle M., Tees, Michael, Parikh, Sameer, Phillips, Tycel, Ghori, Razi, Paydar, Ima, Farooqui, Mohammed Z. H., Byrd, John C., Stephens, Deborah
Publicado 2023

Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001

por Stephens, Deborah M., Li, Hongli, Constine, Louis S., Fitzgerald, Thomas J., Leonard, John P., Kahl, Brad S., Song, Joo Y., LeBlanc, Michael L., Smith, Sonali M., Persky, Daniel O., Friedberg, Jonathan W.
Publicado 2022

Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy

por Rock, Calvin B., Chipman, Jonathan J., Parsons, Matthew W., Weil, Chris R., Hutten, Ryan J., Tao, Randa, Tward, Jonathan D., Shah, Harsh R., Hu, Boyu, Stephens, Deborah M., Gaffney, David K.
Publicado 2022

Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL

por Siddiqi, Tanya, Soumerai, Jacob D., Dorritie, Kathleen A., Stephens, Deborah M., Riedell, Peter A., Arnason, Jon, Kipps, Thomas J., Gillenwater, Heidi H., Gong, Lucy, Yang, Lin, Ogasawara, Ken, Thorpe, Jerill, Wierda, William G.
Publicado 2022

The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021

por Goyal, Gaurav, Lau, Krystal W., Wang, Xiaoliang, Davidoff, Amy J., Huntington, Scott F., Jamy, Omer, Calip, Gregory, Shah, Harsh, Stephens, Deborah M., Miksad, Rebecca, Parikh, Ravi B., Takvorian, Samuel, Neparidze, Natalia, Seymour, Erlene K.
Publicado 2023

Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center

por Stephens, Deborah M., Ruppert, Amy S., Jones, Jeffrey, Woyach, Jennifer, Maddocks, Kami, Jaglowski, Samantha, Andritsos, Leslie A., Flynn, Joseph M., Grever, Michael R., Lozanski, Gerard, Johnson, Amy J., Muthusamy, Natarajan, Heerema, Nyla A., Byrd, John C.
Publicado 2014

Racial Disparities in Telemedicine Uptake during the COVID-19 Pandemic Among Patients with Hematologic Malignancies in the United States

por Neparidze, Natalia, Lau, Krystal W., Wang, Xiaoliang, Davidoff, Amy J., Huntington, Scott F., Jamy, Omer Hassan, Calip, Gregory, Shah, Harsh, Stephens, Deborah M., Miksad, Rebecca A., Parikh, Ravi, Takvorian, Samuel, Goyal, Gaurav, Seymour, Erlene K
Publicado 2021

Impact of the COVID-19 Pandemic on in-Person Visit Rates Among Patients with Hematologic Malignancies in the United States

por Goyal, Gaurav, Lau, Krystal W., Wang, Xiaoliang, Davidoff, Amy J., Huntington, Scott F., Jamy, Omer Hassan, Calip, Gregory, Shah, Harsh, Stephens, Deborah M., Miksad, Rebecca A., Parikh, Ravi, Takvorian, Samuel, Neparidze, Natalia, Seymour, Erlene K
Publicado 2021

Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients

por Brown, Jennifer R., Byrd, John C., Ghia, Paolo, Sharman, Jeff P., Hillmen, Peter, Stephens, Deborah M., Sun, Clare, Jurczak, Wojciech, Pagel, John M., Ferrajoli, Alessandra, Patel, Priti, Tao, Lin, Kuptsova-Clarkson, Nataliya, Moslehi, Javid, Furman, Richard R.
Publicado 2021

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patie...

por Viviani, Simonetta, Pavoni, Chiara, Barrington, Sally F., Guerra, Luca, Schöder, Heiko, Johnson, Peter, Kirkwood, Amy A., Stephens, Deborah M., Friedberg, Jonathan W., Chauvie, Stephane, Knopp, Michael V., Federico, Massimo, Enblad, Gunilla, Corradini, Paolo, Gallamini, Andrea, Rambaldi, Alessandro, Tarella, Corrado
Publicado 2022